SectorPharmaceutical
Established Date18/12/2000
Listing Date17/03/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees1796
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office address48th Floor, heung Kong Center, 2 Queen’s Road Central, Hong Kong
BusinessHutchison Pharmaceuticals (China) Co., Ltd. (the 'Company ') and its subsidiaries (collectively the' Group ') are principally engaged in the research and development, production and marketing of pharmaceuticals.
IntroductionHutchison Pharmaceuticals (China) Co., Ltd. is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The company operates its business primarily through two divisions. The Tumor Immunology business segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immune diseases. R & D includes R&D activities covering drug discovery, development, production and regulatory functions. Listed products include the invoiced sales, promotion, production and distribution of drugs developed through R&D activities. Other business segments are engaged in other commercialization businesses, including the sales, promotion, production and distribution of other prescription drugs and health products.